Patrick D Walsh
CIK 1720568 · CHAIRMAN, INTERIM PRES. & CEO · last filed 2026-05-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.48M
Companies
5
Total Filings
31
Lifetime Open-Market Net
-$2.21M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 48,432 | $71.92 | $3.48M | -$2.42M | 15 | 2026-05-13 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 40,000 | $8.76 | $350.4K | $112.6K | 3 | 2021-06-08 |
| Avid Bioservices, Inc. (CDMOP) Delisted | Director | 30,000 | $25.06 | $751.8K | $96.6K | 4 | 2020-12-16 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | Director | 3,791 | $14.49 | $54.9K | $0 | 2 | 2019-04-01 |
| Avid Bioservices, Inc. (PPHMP) Delisted | Director | — | — | — | $0 | 1 | 2017-10-24 |
Recent Filings · Page 3 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-12 | ANIP | Buy (P) | +5,000 | $129.8K | EDGAR |
| 2020-10-16 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-12 | ANIP | Buy (P) | +10,000 | $307.8K | EDGAR |
| 2020-05-13 | ANIP | Grant (A) | +7,050 | $0 | EDGAR |
| 2020-04-14 | ANIP | Grant (A) | +9,255 | $0 | EDGAR |
| 2020-03-25 | Avid Bioservices, Inc. (CDMOP) Delisted | Buy (P) | +30,000 | $96.6K | EDGAR |
| 2020-01-13 | Avid Bioservices, Inc. (CDMOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-01 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Grant (A) | +1,991 | $0 | EDGAR |
| 2018-12-18 | Avid Bioservices, Inc. (CDMOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Grant (A) | +1,800 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.